Stockysis — AI-Powered Stock News & Sentiment Analysis

Calidi Biotherapeutics shares are trading lower after the company announced the pricing of its $5.2 million offering of 10.5 million shares.

Benzinga Newsdesk www.benzinga.com Negative 96.8%

Neg 96.8% Neu 0% Pos 0%

Comments

No comments yet. Be the first!